CiRC Biosciences

About:

CiRC Biosciences is a biotech company developing potential cell therapy treatments for vision loss conditions.

Website: https://circbiosciences.com/

Description:

CiRC Biosciences operates in the biotechnology industry, focusing on the development of potential cell therapy treatments. The company is currently in the pre-clinical development stage for a treatment for retinitis pigmentosa (RP) and dry age-related macular degeneration. These conditions are related to vision loss, and CiRC Biosciences is working on innovative solutions to address them. The company is a portfolio company of Paragon Biosciences.

Total Funding Amount:

$23.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Chicago, Illinois, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)circbiosciences.com

Founders:

Sai Chavala

Number of Employees:

1-10

Last Funding Date:

2024-05-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai